Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) [Phase 1]
A Phase 1 biomarker study of MK-8237 (SCH900237) in participants with allergic rhinitis or rhinoconjunctivitis has completed with results po…
-
FDA approval · 2017-02-09FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) from Chattem, Inc., approving changes to the product's la…
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Cellulose Powder Against Grass Pollen Allergic Rhinitis [Phase 2, Phase 3]
Update on Phase 2 and Phase 3 trials evaluating cellulose powder for grass pollen-induced allergic rhinitis, conducted by Nasaleze Internati…
-
FDA approval · 2017-01-31FDA Approved: CHILDRENS XYZAL ALLERGY — Original Application (Chattem, Inc.)
FDA approved the original application for CHILDRENS XYZAL ALLERGY (levocetirizine dihydrochloride) by Chattem, Inc.
-
FDA approval · 2017-01-31FDA Approved: XYZAL ALLERGY 24HR — Original Application (Chattem, Inc.)
FDA Approved: XYZAL ALLERGY 24HR (levocetirizine dihydrochloride) by Chattem, Inc. under an Original Application. The product is indicated f…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-30Clinical Trial Update: A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies [Phase 2]
A phase 2 study evaluating the safety and pharmacodynamics of repeat intranasal dosing of the TLR7 agonist GSK2245035 in subjects with asthm…
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Safety and Tolerability of XmAb®7195 in Adult Healthy Volunteers and Adult Subjects With a History of Allergic Rhinitis and/or Allergic Conjunctivitis and/or Atopic Dermatitis [Phase 1]
A Phase 1 study evaluated the safety and tolerability of XmAb7195 in healthy adults and adults with allergic rhinitis, allergic conjunctivit…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Effect of Different Pre-seasonal BM32 Dosings on the Induction of a Protective Immune Response [Phase 2]
Phase 2 trial evaluating different pre-seasonal BM32 dosing regimens to induce a protective immune response. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber [Phase 2]
A Phase 2 dose-response study evaluating the SQ Tree SLIT-tablet for allergic rhinoconjunctivitis using an environmental exposure chamber; t…
-
CLINICAL_TRIALS trial_result · 2017-01-19Clinical Trial Update: Effects of Whole Sprouts on Airway Allergic Inflammation [NA]
A completed clinical trial assessed the effects of whole sprouts on airway allergic inflammation in individuals with allergic rhinitis and a…
-
CLINICAL_TRIALS trial_result · 2017-01-16Clinical Trial Update: Effects of Bilastine on F1 Simulator Driving Performance in Patients Affected by Allergic Rhinitis and/or Urticaria [Phase 4]
Phase 4 trial evaluating bilastine's effect on F1 simulator driving performance in patients with allergic rhinitis and/or urticaria. Results…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Effects of Hypertonic Saline Solution (NACL 3%+NAHCO3) on Nasal Inflammation in Children With AR. RinASol- Pilot Study [Phase 4]
A Phase 4 pilot trial evaluated the effects of hypertonic saline solution (3% NaCl plus bicarbonate) on nasal inflammation in children with …
-
FDA approval · 2016-12-27FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
The FDA approved a supplemental application for Apotex Corp.'s azelastine hydrochloride product, confirming regulatory approval for this gen…
-
CLINICAL_TRIALS trial_result · 2016-12-26Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 [Phase 3]
A Phase 3 clinical trial evaluating CKD-342 for perennial allergic rhinitis has completed.
-
FDA approval · 2016-12-22FDA Approved: AZELASTINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for azelastine hydrochloride from Sun Pharmaceutical Industries, updating the approved generic p…
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409) [Phase 3]
Phase 3 safety study evaluating the combination of ciclesonide nasal spray with inhaled fluticasone propionate/salmeterol in adults with per…
-
CLINICAL_TRIALS research · 2016-12-05Clinical Trial Update: ATEM (Alvesco Non-interventional Study)
This update covers a completed non-interventional study of Alvesco (ciclesonide) in asthma and allergic conditions.
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) [Phase 3]
This clinical trial update reports on the safety and effectiveness of ciclesonide nasal spray for treating perennial allergic rhinitis in ch…
-
CLINICAL_TRIALS trial_result · 2016-12-02Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]
A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-30Clinical Trial Update: Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) [Phase 3]
Phase 3 study update assessing safety and effectiveness of ciclesonide nasal spray for perennial allergic rhinitis over one year; study comp…
-
CLINICAL_TRIALS trial_result · 2016-11-18Clinical Trial Update: A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber [Phase 2]
A completed Phase 2 trial evaluated QAW039 (fevipiprant) and montelukast, alone and in combination, for allergic rhinitis using an environme…
-
CLINICAL_TRIALS research · 2016-11-17Clinical Trial Update: Specific Immunotherapy for Allergic Child [NA]
Clinical trial update on a specific immunotherapy for allergic children addressing allergic rhinitis, asthma, and grass pollen allergy; curr…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Sun Pharmaceutical Industries, Inc., under the existing ANDA.
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for cetirizine hydrochloride by Padagis Israel Pharmaceuticals Ltd. The document indicates the actio…
-
FDA approval · 2016-11-08FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for cetirizine hydrochloride from PAI Holdings, LLC dba PAI Pharma. This action approves a supplemen…